These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21843937)

  • 21. Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers.
    Kim HS; Kim Y; Doddareddy MR; Seo SH; Rhim H; Tae J; Pae AN; Choo H; Cho YS
    Bioorg Med Chem Lett; 2007 Jan; 17(2):476-81. PubMed ID: 17092715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.
    Kang B; Oh JA; Lee JY; Rhim H; Yune TY; Park Choo HY
    Bioorg Med Chem; 2015 Sep; 23(18):6166-72. PubMed ID: 26296911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
    Rhim H; Lee YS; Park SJ; Chung BY; Lee JY
    Bioorg Med Chem Lett; 2005 Jan; 15(2):283-6. PubMed ID: 15603940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
    Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and SAR study of T-type calcium channel blockers. Part II.
    Choe YJ; Seo HN; Jung SY; Rhim H; Kim J; Choo DJ; Lee JY
    Arch Pharm (Weinheim); 2008 Oct; 341(10):661-4. PubMed ID: 18816587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonists.
    McCalmont WF; Heady TN; Patterson JR; Lindenmuth MA; Haverstick DM; Gray LS; Macdonald TL
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3691-5. PubMed ID: 15203145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First pharmacophoric hypothesis for T-type calcium channel blockers.
    Doddareddy MR; Jung HK; Lee JY; Lee YS; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1605-11. PubMed ID: 15028253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain.
    Kim JH; Nam G
    Bioorg Med Chem; 2016 Nov; 24(21):5028-5035. PubMed ID: 27591007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
    Du Nguyen H; Okada T; Kitamura S; Yamaoka S; Horaguchi Y; Kasanami Y; Sekiguchi F; Tsubota M; Yoshida S; Nishikawa H; Kawabata A; Toyooka N
    Bioorg Med Chem; 2018 Aug; 26(15):4410-4427. PubMed ID: 30031654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery, structure-activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity.
    Yamamoto T; Niwa S; Iwayama S; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Yamamoto H; Shoji M
    Bioorg Med Chem; 2006 Aug; 14(15):5333-9. PubMed ID: 16616501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological studies of Cav3.1 T-type calcium channels using automated patch-clamp techniques.
    Choi KH; Song C; Cheong CS; Rhim H
    Gen Physiol Biophys; 2011 Mar; 30(1):100-5. PubMed ID: 21460418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity.
    Kam YL; Rhee HK; Rhim H; Back SK; Na HS; Choo HY
    Bioorg Med Chem; 2010 Aug; 18(16):5938-44. PubMed ID: 20659804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.
    Shao PP; Ye F; Chakravarty PK; Varughese DJ; Herrington JB; Dai G; Bugianesi RM; Haedo RJ; Swensen AM; Warren VA; Smith MM; Garcia ML; McManus OB; Lyons KA; Li X; Green M; Jochnowitz N; McGowan E; Mistry S; Sun SY; Abbadie C; Kaczorowski GJ; Duffy JL
    J Med Chem; 2012 Nov; 55(22):9847-55. PubMed ID: 23098566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers.
    Ku IW; Cho S; Doddareddy MR; Jang MS; Keum G; Lee JH; Chung BY; Kim Y; Rhim H; Kang SB
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5244-8. PubMed ID: 16876404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
    Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY
    Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.
    Choi YJ; Seo JH; Shin KJ
    Bioorg Med Chem Lett; 2014 Feb; 24(3):880-3. PubMed ID: 24412109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core.
    Hangeland JJ; Cheney DL; Friends TJ; Swartz S; Levesque PC; Rich AJ; Sun L; Bridal TR; Adam LP; Normandin DE; Murugesan N; Ewing WR
    Bioorg Med Chem Lett; 2008 Jan; 18(2):474-8. PubMed ID: 18160281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The biochemical activation of T-type Ca2+ channels in HEK293 cells stably expressing alpha1G and Kir2.1 subunits.
    Kim T; Choi J; Kim S; Kwon O; Nah SY; Han YS; Rhim H
    Biochem Biophys Res Commun; 2004 Nov; 324(1):401-8. PubMed ID: 15465033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.